According to this study published by the Karolinska Institute in Stockholm in JAMA Neurology this week, there is a statistical association between Alzheimer’s disease and shorter telomeres via the single nucleotide polymorphisms associated with telomere shortening.
Well, the FDA just informed the company to stop because of lack of “scientific evidence” so that has saved me from doing any diligence on this test, which I must admit didn’t feel like it was really due much anyway.